Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL February 2025 Clinical trials Read more
2020 June EHA 2020 PODCAST: prof. dr. Arnon Kater about venetoclax monotherapy in CLL patients Read more
2020 June EHA 2020 PODCAST: dr. Efstathios Kastritis about the use of daratumumab in AL amyloidosis Read more
2020 June EHA 2020 PODCAST: prof. Tiziano Barbui about ropeginterferon in patients with polycythemia vera Read more
2020 May Clinical trials 100% response to new CAR-T cell therapy in R/R multiple myeloma patients Read more